DYAI · Dyadic International Inc · Webcasts, Transcripts & Audio
$0.34
0.00 (-0.09%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, our management has concluded that there is substantial doubt about our ability to continue as a going concern, which depends upon our obtaining necessary financing to meet our obligations and repay our liabilities arising from normal business operations as they come due.”View the 10-Q filed Aug 12, 2026
Market Cap
$12.38M
Shares
36.44M
Volume · Nov 6
67.03K
Avg daily vol (3M)
155.84K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Dyadic International Inc Webcasts
Earnings calls, investor updates, investor days and conferences for Dyadic International Inc (DYAI), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q2
2026-08-12
Dyadic International Inc (DYAI) Q2 2026 Earnings Call Transcript
Positive tone
Partner Programs and Revenue Ramp
Going Concern and Liquidity
Non-Dilutive Financing Strategy
Revenue
$961,138
▼ 0.6% YoY Diluted EPS
$-0.06
Gross margin
-2.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Dyadic International Inc (DYAI) Q1 2026 Earnings Call Transcript
Confident tone
Life sciences and cell culture media products
Cultivated meat market opportunity
Food, nutrition and dairy proteins
Revenue
$1.11M
▲ 182.3% YoY Diluted EPS
$-0.05
Gross margin
28.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-25
Dyadic International Inc (DYAI) Q4 2025 Earnings Call Transcript
Confident tone
Partnerships and distribution
Life sciences / recombinant proteins
Food and nutrition
Revenue
$565,526*
▼ 30.8% YoY Gross margin
32.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Dyadic International Inc (DYAI) Q3 2025 Earnings Call Transcript
Confident tone
Life sciences portfolio (albumin, transferrin, DNase I, FGF)
Commercial transformation and first product sales
ProLiant Health and Biologics partnership (albumin)
Revenue
$1.16M
▼ 40.5% YoY Diluted EPS
$-0.06
Gross margin
12.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Dyadic International Inc (DYAI) Q2 2025 Earnings Call Transcript
Confident tone
Life sciences / cell culture media products
Bioindustrial and non-therapeutic market focus
Food nutrition and dairy alternatives
Revenue
$966,630
▲ 150.5% YoY Diluted EPS
$-0.06
Gross margin
36.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Dyadic International Inc (DYAI) Q1 2025 Earnings Call Transcript
Positive tone
Industrial enzymes and Fermbox
Cell culture media and albumin
Funded collaborations and grants
Revenue
$393,572
▲ 17.6% YoY Diluted EPS
$-0.07
Gross margin
24.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-04-23
Dyadic International Inc (DYAI) Q4 2024 Earnings Call
Revenue
$817,376*
▲ 19.1% YoY Gross margin
56.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2025-03-30
Dyadic International Inc (DYAI) March 30, 2025 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY24 · Q3
2024-11-12
Dyadic International Inc (DYAI) Q3 2024 Earnings Call Transcript
Confident tone
Alternative proteins commercialization (Dapibus platform)
Life science / molecular biology product launches
Cell culture media and cultured meat opportunity
Revenue
$1.96M
▲ 393% YoY Diluted EPS
$-0.01
Gross margin
79.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-13
Dyadic International Inc (DYAI) Q2 2024 Earnings Call Transcript
Confident tone
Proliant Partnership and Serum Albumin
Cell Culture Media and Transferrin
Non-Animal Dairy Products
Revenue
$385,896
▼ 53.9% YoY Diluted EPS
$-0.07
Gross margin
21.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Dyadic International Inc (DYAI) Q1 2024 Earnings Call Transcript
Confident tone
Animal Health and H5N1 Bird Flu
Regulatory Pathway and FDA Engagement
Phase I DYAI-100 COVID Vaccine Results
Revenue
$334,617
▼ 65.8% YoY Gross margin
57.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-28
Dyadic International Inc (DYAI) Q4 2023 Earnings Call Transcript
Confident tone
Alternative proteins / Dapibus platform
Animal health and infectious disease vaccines
Equity-for-services deal strategy
Revenue
$686,535*
▼ 7.7% YoY Gross margin
49.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Dyadic International Inc (DYAI) Q3 2023 Earnings Call Transcript
Revenue
$397,060
▼ 54.9% YoY Gross margin
73.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Dyadic International Inc (DYAI) Q2 2023 Earnings Call Transcript
Revenue
$837,159
▲ 27.1% YoY Gross margin
5.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Dyadic International Inc (DYAI) Q1 2023 Earnings Call Transcript
Revenue
$978,052
▲ 50.8% YoY Gross margin
25.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-29
Dyadic International Inc (DYAI) Q4 2022 Earnings Call Transcript
Revenue
$743,726*
Gross margin
5.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Dyadic International Inc (DYAI) Q3 2022 Earnings Call Transcript
Revenue
$879,597
▲ 26.9% YoY Gross margin
31.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
Dyadic International Inc (DYAI) Q2 2022 Earnings Call Transcript
Revenue
$658,553
▼ 29.7% YoY Gross margin
37.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Dyadic International Inc (DYAI) Q1 2022 Earnings Call Transcript
Revenue
$648,427
▼ 99.9% YoY Gross margin
37.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-29
Dyadic International Inc (DYAI) Q4 2021 Earnings Call Transcript
Revenue
−$459.75M*
▼ 133006.5% YoY Gross margin
15.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Dyadic International Inc (DYAI) Q3 2021 Earnings Call Transcript
Revenue
$692,929
▲ 66.4% YoY Gross margin
43.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Dyadic International Inc (DYAI) Q2 2021 Earnings Call Transcript
Revenue
$937,092
▲ 78.7% YoY Gross margin
11.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Dyadic International Inc (DYAI) Q1 2021 Earnings Call Transcript
Revenue
$460.52M
▲ 145924.4% YoY Gross margin
15.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-30
Dyadic International Inc (DYAI) Q4 2020 Earnings Call Transcript
Revenue
$345,917*
▼ 20.1% YoY Gross margin
26.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-12
Dyadic International Inc (DYAI) Q3 2020 Earnings Call Transcript
Revenue
$416,361
▼ 8.4% YoY Gross margin
35.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-13
Dyadic International Inc (DYAI) Q2 2020 Earnings Call Transcript
Revenue
$524,271
▲ 34.1% YoY Gross margin
-19.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-14
Dyadic International Inc (DYAI) Q1 2020 Earnings Call Transcript
Revenue
$315,372
▼ 21.7% YoY Gross margin
11.8%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-30
Dyadic International Inc (DYAI) Q4 2019 Earnings Call
Revenue
$433,168*
▼ 36.9% YoY Gross margin
1.9%
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 webcasts
Key facts
CIK
1213809
CUSIP
26745T101
13F (30d)
18 filings
18 filers
Visit website
Investor relations